Organ
transplantation in one of the greatest innovations in the healthcare industry
indeed. This technology has come a long way in the past couple of years. With a lot of advancements and modern
medicine, organ transplantation has been providing benefits to patients
suffering from an end stage chronic disease that lead to organ
dysfunction and cannot be treated with normal medication.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1135
Singapore Transplant
diagnostics are the tests conducted before or after transplant in order to
check the compatibility betwesen the donor and recipient of organ. It is an
important component of clinical evaluations of multiple attributes
related to donor organ screening and recipient surveillance.
The North America is currently
holding the highest market share, owing to a significant rise in prevalence of chronic diseases, increase in adoption rate of transplant of organs, and surge in need
for efficient & effective management of transplant diagnostic methods.
The Asia-Pacific
region, at the same time, is expected to witness the fastest growth rate. This
is due to certain factors such as rise in number of geriatric population who
need kidney dialysis services, the huge base of hospital & transplant centers,
and surge in R&D activities in the emerging economies like India, China,
others. A significant increase in awareness regarding donation of organs among
millennials is also contributing to the growth of the market to a great extent.
With this drift on
board, several biotechnology enterprises have sparked
interest in investing more in the development of innovative organ transplant
diagnostic tools. They are focusing on the development of reliable
transplant diagnostic solutions for research purposes that can help transplant
physicians and researchers in better understanding the intricacies of
transplant treatment. For instance, a company named Natera has recently
launched its latest addition to transplant monitoring portfolio i.e. Prospera donor derived transplant assessment test for lung
transplant recipients. This factor is augmenting the
growth of the Singapore transplant diagnostic
market in more than one way.
In addition,
numerous key market players are adopting strategies such as partnerships,
collaborations, and acquisitions in order to stay competitive in the Singapore market.
For example, Siemens in partnership with Thermo Fisher Scientific integrated Thermo
Fisher Scientific’s real time PCR technology that can offer fast &
sensitive detection limit, thereby can enhance the overall duration and quality
of diagnostics.
Also, Thermo Fisher Scientific acquired Linkage Biosciences with an aim to
provide services to more than 1000 transplant centers in over 60 countries. Here it is worth mentioning that the global
transplant diagnostic market has a great scope to gather immense growth
opportunities in the near future.
𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/transplant-diagnostics-market
0 Comments